Afuco™ Anti-Human ESR2 ADCC Therapeutic Antibody (Mayo MC10), ADCC Enhanced

Anti-ESR2 ADCC Enhanced Antibody (Mayo MC10) is an ADCC enhanced antibody produced by our Afuco™ platform. The use of the MC10 antibody, in combination with highly specific antibodies targeting only full-length ERα, is likely to provide additional discriminatory features in breast cancers that may be useful in predicting response to therapy.
Supplier Creative Biolabs
Product # AFC-237CL
Pricing Inquiry
Host Human
Target ESR2
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles.
Feedback